Based on the association of infiltrating B cell and DC levels with prognosis in LUAD, we further explored whether the combined analysis of TSKU expression and infiltrating B cell (or DC) levels yielded different prognoses in NSCLC patients. This evidence concerns the gene TSKU and non-small cell lung carcinoma.